CONCORD BIOTECH
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Concord Biotech along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-2.18₹ -34.6
As on Sep 26, 2025, 2:56 PM IST
Concord Biotech Price Performance
Today's LowToday's High
₹1,524.00₹1,583.00
₹1,556.20
52 Weeks' Low52 Weeks' High
₹1,370.05₹2,451.65
₹1,556.20
Open Price
₹1,568.40
Prev. Close
₹1,590.80
Volume
9,894
Over the last 5 years, the share price of Concord Biotech has gained 10.56% CAGR. Over the past year, the corresponding return has been -26.83%.
Concord Biotech’s current P/E of 45.63x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Concord Biotech Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Concord Biotech | -8.16 | -8.89 | -13.56 | -6.30 | -26.94 | 18.13 | 10.51 |
| Sun Pharmaceutical Industries | -4.61 | -1.30 | -5.37 | -10.13 | -16.79 | 20.71 | 25.34 |
| Divi's Laboratories | -8.07 | -7.95 | -13.84 | -2.42 | 5.94 | 15.83 | 13.01 |
| Cipla | -4.94 | -5.20 | -0.99 | 1.50 | -7.67 | 12.01 | 14.09 |
| Torrent Pharmaceuticals | -2.24 | -1.46 | 10.05 | 10.27 | 4.11 | 32.85 | 21.40 |
| Dr. Reddy's Laboratories | -4.99 | -0.53 | -4.88 | 7.98 | -6.82 | 14.96 | 4.13 |
| Mankind Pharma | -6.60 | -0.62 | 7.93 | 3.23 | -7.42 | 20.39 | 11.78 |
| Zydus Lifesciences | -5.12 | -0.36 | 0.19 | 8.48 | -7.90 | 40.33 | 20.29 |
| Lupin | -6.67 | -0.25 | -0.37 | -6.75 | -12.27 | 43.11 | 13.73 |
| Alkem Laboratories | -1.83 | 0.29 | 12.18 | 8.70 | -12.35 | 18.19 | 14.41 |
| Abbott India | -0.67 | -5.74 | -9.20 | -1.59 | 3.11 | 19.62 | 13.02 |
| Aurobindo Pharma | -2.74 | 4.06 | -3.16 | -6.00 | -28.23 | 29.40 | 6.29 |
| Glenmark Pharmaceuticals | -5.72 | 0.66 | 13.51 | 34.24 | 17.20 | 74.81 | 31.74 |
| Biocon | -7.45 | -4.70 | -2.51 | -1.88 | -8.26 | 7.38 | -5.37 |
| GlaxoSmithKline Pharmaceuticals | -2.36 | -4.12 | -18.93 | -5.22 | -1.95 | 24.32 | 11.13 |
| Laurus Labs | -10.58 | -4.05 | 22.43 | 35.55 | 79.78 | 18.99 | 23.36 |
| Anthem Biosciences | -7.17 | -5.88 | 7.63 | 7.63 | 7.63 | 2.51 | 1.50 |
| Ipca Laboratories | -4.19 | -4.22 | 1.89 | -5.08 | -7.37 | 15.20 | 5.64 |
| Cohance Lifesciences | -4.17 | -1.07 | -13.03 | -21.73 | -25.96 | 27.69 | 16.83 |
| Gland Pharma | -2.79 | 1.92 | 9.64 | 21.39 | 6.41 | -1.72 | 1.48 |
Over the last one year, Concord Biotech has declined 26.94% compared to peers like Sun Pharmaceutical Industries (-16.79%), Divi's Laboratories (5.94%), Cipla (-7.67%). From a 5 year perspective, Concord Biotech has underperformed peers relative to Sun Pharmaceutical Industries (25.34%) and Divi's Laboratories (13.01%).
Concord Biotech Financials
Concord Biotech Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,645.24 | 1,620.77 |
| 10 | 1,644.61 | 1,632.06 |
| 20 | 1,655.68 | 1,647.81 |
| 50 | 1,720.6 | 1,690.39 |
| 100 | 1,732.71 | 1,726.97 |
| 200 | 1,823.56 | 1,751.12 |
Concord Biotech Share Holding Pattern
In the latest quarter, Concord Biotech remained same as its previous close in promoter holding, while DII stake decreased to 8.85%, FII holding fell to 9.10%, and public shareholding moved up to 37.94% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Concord Biotech Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| HSBC Small Cap Fund - Regular Plan | 8,53,962 | 0.9 | 143.61 |
| SBI Healthcare Opportunities Fund | 7,20,000 | 3.06 | 121.08 |
| DSP Healthcare Fund | 4,89,774 | 2.65 | 82.37 |
| Invesco India Smallcap Fund | 3,30,193 | 0.72 | 55.53 |
| Baroda BNP Paribas Balanced Advantage Fund | 2,80,000 | 1.09 | 47.09 |
| Baroda BNP Paribas Multi Cap Fund | 2,59,075 | 1.49 | 43.57 |
| Invesco India Multicap Fund | 2,26,042 | 0.94 | 38.01 |
| Invesco India Flexi Cap Fund | 1,50,109 | 0.69 | 25.24 |
| Edelweiss Small Cap Fund | 1,45,577 | 0.5 | 24.48 |
| Baroda BNP Paribas Large and Mid Cap Fund | 1,40,000 | 1.47 | 23.54 |
Concord Biotech Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 11, 2025, 8:48 PM IST | Concord Biotech Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 11, 2025, 8:44 PM IST | Concord Biotech Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 11, 2025, 8:19 PM IST | Concord Biotech Ltd. - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 09, 2025, 11:23 PM IST | Concord Biotech Ltd. - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Aug 21, 2025, 7:43 PM IST | Concord Biotech Ltd. - Successful Completion Of EU GMP Inspection |
About Concord Biotech
Concord Biotech Ltd. is a Public Limited Listed company incorporated on 23/11/1984 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1984PLC007440 and registration number is 007440. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1200.09 Cr. and Equity Capital is Rs. 10.46 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address1482-1486, Trasad Road, Ahmedabad Gujarat 382225
- Contact
Management
- Mr. Sudhir VaidChairman & Managing Director
- Mr. Ankur VaidJoint Managing Director & CEO
- Mr. Ravi KapoorNon Executive Director
- Mr. Rajiv Ambrish AgarwalNon Executive Director
- Mrs. Bharti KhannaIndependent Director
- Mr. Amitabh ThakoreIndependent Director
- Mr. Arvind AgarwalIndependent Director
- Mr. Jayaram EaswaranIndependent Director
- Mr. Mandayam Chakravarthy SriramanIndependent Director
FAQs on Concord Biotech Share Price
What is the share price of Concord Biotech?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Concord Biotech is ₹1,556.20 as on Sep 26, 2025.
What kind of stock is Concord Biotech?
The Concord Biotech is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Concord Biotech?
The market cap of Concord Biotech is ₹16,248.99 Cr as on Sep 26, 2025.
What are today's High and Low prices of Concord Biotech?
Today’s highest and lowest price of Concord Biotech are ₹1,583.00 and ₹1,524.00.
What are the 52 Week High and 52 Week Low of Concord Biotech?
The 52-week high/low is the highest and lowest price at which Concord Biotech stock has traded in the past 52-week or nearly a year. The 52-week high of Concord Biotech is ₹2,451.65 and 52-week low of Concord Biotech is ₹1,370.05 as on Sep 26, 2025.
How has the Concord Biotech performed historically in terms of returns?
The Concord Biotech has shown returns of -2.28% over the past day, -8.82% for the past month, -13.5% over 3 months, -26.89% over 1 year, 18.18% across 3 years, and 10.54% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Concord Biotech?
P/E ratio of and PB ratio of Concord Biotech are 45.63 and 10.22 on Sep 26, 2025. While the company gives a dividend yield of 0.69 per annum.
Trending In Market
Mutual Funds Screener
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data